GW Pharmaceuticals Ltd

Quick facts

Phase 3 pipeline

• Placebo (GA-0034)
  Placebo (GA-0034) is an inert control substance with no active pharmacological mechanism.

Phase 2 pipeline

• Sativex High Dose
• Sativex Low Dose
• Sativex Medium Dose

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• GW Pharmaceuticals Ltd portfolio CI brief
• GW Pharmaceuticals Ltd pipeline updates RSS